Physical exercise improves the functional capacity and quality of life in patients with heart failure
AUTOR(ES)
Bocalini, Danilo Sales, Santos, Leonardo dos, Serra, Andrey Jorge
FONTE
Clinics
DATA DE PUBLICAÇÃO
2008
RESUMO
OBJECTIVE: The purpose of this study was to investigate the effects of physical exercise on the functional capacity and quality of life in heart failure patients. METHODS: Forty-two patients of both sexes with heart failure of NYHA class II and III with different etiologies were randomly divided into untrained or trained groups. The six-month exercise program consisted of aerobic training, muscle strength training, agility and joint flexibility activities. Physical fitness was evaluated by testing the performance on these trained components. Quality of life was evaluated by scored answers to a standardized questionnaire involving multiple domains. RESULTS: Baseline values did not differ between groups. Improvement in the trained group was identified in all components of functional capacity when compared to the untrained group (p < 0.001). Quality of life improved in the trained patients concerning physical, psychological, social and environmental domains (p < 0.001), whereas no significant change was found in the untrained patients. CONCLUSIONS: Guided and monitored physical exercise is safe and has the potential to improve functional capacity and quality of life in heart failure patients with multiple etiologies.
Documentos Relacionados
- Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction
- Physical Exercise in the Management of Erectile Dysfunction in Patients with Heart Failure
- Collaborative care model improves self-care ability, quality of life and cardiac function of patients with chronic heart failure
- PHYSICAL ACTIVITY IN DAILY LIFE, EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE ON INFLIXIMAB-INDUCED REMISSION: A PRELIMINARY STUDY
- Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial.